Developer docs
API playgroundTry for free, no card

Search company profiles

Hannover Medical School

Full company profile

uuid0006z7c

Namestring
Hannover Medical School
Legal namestring
Medizinische Hochschule Hannover
Websiteurl
mh-hannover.de
Company typeenum
Private
Founded yearint
1965
Descriptiontext

Hannover Medical School (Medizinische Hochschule Hannover, MHH) is a German public university medical center established in 1965 in Hannover, Lower Saxony, operating as an integrated hospital, biomedical research institution, and academic medical school with 5,001-10,000 employees. The institution delivers inpatient and outpatient clinical care across all major specialties with particular depth in transplantation medicine, rare diseases, oncology, and cardiology, while also running medical degree, doctoral, and habilitation programs through the Hannover Biomedical Research School (HBRS). It serves three primary constituencies: general public patients (including international patients via a dedicated International Patient Service), medical students and clinician scientists, and the broader research community and clinical trial partners.

MHH's research portfolio spans digital health (wearable physiologic monitoring and AI-driven biomarker analytics), RNA therapeutics (a Phase 2 microRNA blocker study for post-infarction cardiac repair), personalized additively manufactured dental implants (FOR 5250, DFG-funded at EUR 4.4 million), glaucoma implants, cancer research (Zimmermann-Preis awarded 2026), and infection research in collaboration with TWINCORE and the Helmholtz Centre for Infection Research. Core research infrastructure includes the Hannover Unified Biobank (HUB), the MeDIC data integration center, central electron and laser microscopy facilities, and the BeoNet COVID-19 registry. AI and machine learning capabilities are applied to wearable data analytics (deep learning, anomaly detection), contactless vital sign monitoring (computer vision, radar/Wi-Fi sensing), and predictive analytics for chronic disease intervention.

MHH is not a commercial enterprise; it is a state-law public institution funded primarily through the German public healthcare system, state allocations from Lower Saxony, and competitive research grants (notably from the DFG). Patient billing operates under gesetzliche und private Krankenversicherung frameworks and through the International Patient Service for cross-border patients. Pricing is not publicly disclosed, and revenue figures are not available in the source material. Marketing and outreach span the institutional website, MHH Insights news portal, podcasts, MHHinfo magazine, and active social channels (Facebook, Instagram, YouTube, LinkedIn, Xing), with distribution handled via the Patient Service Center (PSC), direct hospital care, and a centralized International Patient Service office.

Short descriptiontext

Hannover Medical School is a German public university medical center in Hannover founded in 1965, delivering integrated clinical care, biomedical research, and medical education across transplantation, oncology, digital health, and rare diseases. It serves patients, medical students, and research partners through hospital services, the HBRS doctoral program, and international collaborations.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
5,001–10,000
akta.pro rankint
HeadquartersHanover, Germany
HQ citystring
Hanover
HQ countrystring
Germany
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
university medical center, clinical healthcare services, biomedical research, medical education programs, transplantation medicine
Industry2 codes
1Biomedical Sciences & Medical Research Institutes (University-Based)
CodeEDAHAGAIPrimaryYes
2Oncology & Cancer Specialty Hospitals
CodeHLAFAHACPrimaryNo
NAICS code1 code
  • General Medical and Surgical Hospitals62211
SIC code2 codes
  • Services-General Medical & Surgical Hospitals, Nec8062
  • Services-Hospitals8060
Product category
University Hospital and Academic Medical Center Services
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Infrastructure, Others
GTM typeB2B and B2C
B2B and B2C
Offering typeServices
Services
Core offering1 text field

Medizinische Hochschule Hannover (MHH) is a public German university medical center that delivers inpatient and outpatient clinical care across all major specialties (including transplantation, cardiology, oncology, and rare diseases), conducts biomedical and clinical research, and provides academic medical education from undergraduate through postdoctoral levels. The institution operates hospital facilities in Hannover, supports doctoral and clinician-scientist training programs, and runs centralized research infrastructure such as the Hannover Unified Biobank (HUB) and MeDIC.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • Wearable devices generate over 5 gigabytes of data per patient per week, supporting chronic disease monitoring including diabetes, heart failure, and cardiovascular disease
+3 more records
Product overview1 text field

Hannover Medical School (MHH) operates as a medical university and hospital offering healthcare services, academic education, and biomedical research. The institution provides clinical care across multiple specialties including oncology, cardiology, transplantation, and rare diseases, complemented by research programs in clinical research, biomedical research school (HBRS), data integration (MeDIC), biobanking (HUB), and microscopy services. The institution focuses on translating research findings into clinical practice through specialized research facilities and international collaboration networks.

Product and service9 records
1University Hospital Clinical Care
CategoryClinical Healthcare Services
2International Patient Service
CategoryClinical Healthcare Services
3Patient Service Center (PSC)
CategoryClinical Healthcare Services
4Hannover Biomedical Research School (HBRS)
CategoryMedical Education and Training
5MeDIC (Medical Data Integration Center)
CategoryResearch Infrastructure Services
6Hannover Unified Biobank (HUB)
CategoryResearch Infrastructure Services
7Laser Microscopy Facility
CategoryResearch Infrastructure Services
8Medical Degree Programs
CategoryMedical Education and Training
9BeoNet-Register
CategoryResearch Programs
Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-01-01
Description

Collaborative research partnership with Technische Universität Berlin on an international mixed-methods study examining digital transformation in nine healthcare systems (Estonia, Denmark, Poland, Portugal, Israel, Japan, Saudi Arabia, South Africa, and the United States) to derive policy recommendations for Germany. The study has completed 109 expert interviews with quantitative survey planned for late 2025 and results expected in 2026.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Collaborative research center with MHH involvement studying RSV (Respiratory Syncytial Virus) manipulation of immune defense in airway cells. TWINCORE is a joint research institute focused on translational infection research.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Partnership on One-Health research examining how environmental pollutants and stress affect the immune system and microbiome in pregnant women, children, and adolescents. MHH researchers collaborate with HZI scientists on this multi-disciplinary project.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeOthers
Description

German national research center for infection biology with an active collaborative partnership with MHH on One-Health and microbiome research. Not a direct competitor but a key strategic research partner and ecosystem participant.

TypeDirect peer
Description

Europe's largest university hospital and one of Germany's leading academic medical centers, combining clinical care, biomedical research, and medical education across all major specialties. Directly comparable to MHH in mission, structure, and German public-university-hospital operating model.

TypeRegional player
Description

Sweden's premier university hospital affiliated with Karolinska Institutet, combining clinical care and world-class biomedical research. Comparable to MHH in academic-medical-center mission but operates in a different national healthcare system.

4University Hospital Cologne (Uniklinik Köln)
TypeDirect peer
Description

Major German university medical center with comparable size, public-university governance, and integrated research-clinical-education mission to MHH.

5University Hospital of the Ludwig-Maximilians-Universität München (LMU Klinikum)
TypeDirect peer
Description

Comprehensive German university medical center delivering clinical care, biomedical research, and medical education. Directly comparable to MHH in scale, public-university governance, and breadth of specialty services.

TypeDirect peer
Description

Major German university medical center internationally recognized for translational oncology research, complex clinical care, and biomedical innovation. Directly comparable to MHH in combining academic medicine, research infrastructure, and high-acuity specialty services.

TypeDirect peer
Description

Comprehensive German university medical center with comparable breadth of specialty clinical care and biomedical research output to MHH.

8University Hospital Frankfurt (Universitätsklinikum Frankfurt)
TypeDirect peer
Description

German public university medical center delivering integrated clinical care, research, and teaching. Comparable to MHH in mission and structural operating model.

TypeDirect peer
Description

German university hospital with strong research profile in imaging, neuroscience, and translational medicine. Comparable to MHH as a peer German public university medical center with similar operating model.

TypeDirect peer
Description

Hamburg-based university hospital providing full-spectrum clinical care alongside major biomedical research programs. Comparable to MHH in mission, German public-university structure, and translational research focus.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI capability6 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles7 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment1 record

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Hannover Medical School

University Hospital and Academic Medical Center Servicesmh-hannover.de

Hannover Medical School is a German public university medical center in Hannover founded in 1965, delivering integrated clinical care, biomedical research, and medical education across transplantation, oncology, digital health, and rare diseases. It serves patients, medical students, and research partners through hospital services, the HBRS doctoral program, and international collaborations.

What Hannover Medical School does

Hannover Medical School (Medizinische Hochschule Hannover, MHH) is a German public university medical center established in 1965 in Hannover, Lower Saxony, operating as an integrated hospital, biomedical research institution, and academic medical school with 5,001-10,000 employees. The institution delivers inpatient and outpatient clinical care across all major specialties with particular depth in transplantation medicine, rare diseases, oncology, and cardiology, while also running medical degree, doctoral, and habilitation programs through the Hannover Biomedical Research School (HBRS). It serves three primary constituencies: general public patients (including international patients via a dedicated International Patient Service), medical students and clinician scientists, and the broader research community and clinical trial partners.

MHH's research portfolio spans digital health (wearable physiologic monitoring and AI-driven biomarker analytics), RNA therapeutics (a Phase 2 microRNA blocker study for post-infarction cardiac repair), personalized additively manufactured dental implants (FOR 5250, DFG-funded at EUR 4.4 million), glaucoma implants, cancer research (Zimmermann-Preis awarded 2026), and infection research in collaboration with TWINCORE and the Helmholtz Centre for Infection Research. Core research infrastructure includes the Hannover Unified Biobank (HUB), the MeDIC data integration center, central electron and laser microscopy facilities, and the BeoNet COVID-19 registry. AI and machine learning capabilities are applied to wearable data analytics (deep learning, anomaly detection), contactless vital sign monitoring (computer vision, radar/Wi-Fi sensing), and predictive analytics for chronic disease intervention.

MHH is not a commercial enterprise; it is a state-law public institution funded primarily through the German public healthcare system, state allocations from Lower Saxony, and competitive research grants (notably from the DFG). Patient billing operates under gesetzliche und private Krankenversicherung frameworks and through the International Patient Service for cross-border patients. Pricing is not publicly disclosed, and revenue figures are not available in the source material. Marketing and outreach span the institutional website, MHH Insights news portal, podcasts, MHHinfo magazine, and active social channels (Facebook, Instagram, YouTube, LinkedIn, Xing), with distribution handled via the Patient Service Center (PSC), direct hospital care, and a centralized International Patient Service office.

Hannover Medical School firmographics

Firmographics
Name
Hannover Medical School
Legal name
Medizinische Hochschule Hannover
Website
https://mh-hannover.de
Company type
Private
Founded year
1965
Operating status
Operating
Headcount range
5,001–10,000 employees
Short description
Hannover Medical School is a German public university medical center in Hannover founded in 1965, delivering integrated clinical care, biomedical research, and medical education across transplantation, oncology, digital health, and rare diseases. It serves patients, medical students, and research partners through hospital services, the HBRS doctoral program, and international collaborations.
Ownership category
akta.pro rank

Hannover Medical School industry classification

Industry
Product category
University Hospital and Academic Medical Center Services
NAICS
General Medical and Surgical Hospitals (62211)
SIC
Services-General Medical & Surgical Hospitals, Nec (8062), Services-Hospitals (8060)
akta.pro primary industry
Biomedical Sciences & Medical Research Institutes (University-Based) (EDAHAGAI)
akta.pro secondary industry
Oncology & Cancer Specialty Hospitals (HLAFAHAC)

Keywords

  • University medical center
  • Clinical healthcare services
  • Biomedical research
  • Medical education programs
  • Transplantation medicine

Where Hannover Medical School is headquartered

Location

Headquarters

HQ city
Hanover
HQ country
Germany
HQ region
Europe

Offices1 record

Markets served

Hannover Medical School business model

Business model
GTM type
B2B and B2C
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Infrastructure, Others

Distribution channels3 records

Marketing channels5 records

Hannover Medical School product offering

Product offering

Core offering

Medizinische Hochschule Hannover (MHH) is a public German university medical center that delivers inpatient and outpatient clinical care across all major specialties (including transplantation, cardiology, oncology, and rare diseases), conducts biomedical and clinical research, and provides academic medical education from undergraduate through postdoctoral levels. The institution operates hospital facilities in Hannover, supports doctoral and clinician-scientist training programs, and runs centralized research infrastructure such as the Hannover Unified Biobank (HUB) and MeDIC.

Product overview

Hannover Medical School (MHH) operates as a medical university and hospital offering healthcare services, academic education, and biomedical research. The institution provides clinical care across multiple specialties including oncology, cardiology, transplantation, and rare diseases, complemented by research programs in clinical research, biomedical research school (HBRS), data integration (MeDIC), biobanking (HUB), and microscopy services. The institution focuses on translating research findings into clinical practice through specialized research facilities and international collaboration networks.

Differentiator

Problem solved

Functional benefit

Products and services

  • University Hospital Clinical Care
  • International Patient Service
  • Patient Service Center (PSC)
  • Hannover Biomedical Research School (HBRS)
  • MeDIC (Medical Data Integration Center)
  • Hannover Unified Biobank (HUB)
  • Laser Microscopy Facility
  • Medical Degree Programs
  • BeoNet-Register

Quantifiable outcome

  • Wearable devices generate over 5 gigabytes of data per patient per week, supporting chronic disease monitoring including diabetes, heart failure, and cardiovascular disease
  • +3 more outcomes

Companies that use Hannover Medical School

Customer profile

Segments3 records

Ideal customer profiles3 records

Hannover Medical School technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability6 records

Feature4 records

Hannover Medical School partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered core.

  • Technische Universität BerlincoreStrategic or Co-development Partner · 1 January 2026Collaborative research partnership with Technische Universität Berlin on an international mixed-methods study examining digital transformation in nine healthcare systems (Estonia, Denmark, Poland, Portugal, Israel, Japan, Saudi Arabia, South Africa, and the United States) to derive policy recommendations for Germany. The study has completed 109 expert interviews with quantitative survey planned for late 2025 and results expected in 2026.
  • TWINCOREcoreStrategic or Co-development PartnerCollaborative research center with MHH involvement studying RSV (Respiratory Syncytial Virus) manipulation of immune defense in airway cells. TWINCORE is a joint research institute focused on translational infection research.
  • Helmholtz Centre for Infection Research (HZI)coreStrategic or Co-development PartnerPartnership on One-Health research examining how environmental pollutants and stress affect the immune system and microbiome in pregnant women, children, and adolescents. MHH researchers collaborate with HZI scientists on this multi-disciplinary project.

Scale indicators3 records

Recent moves6 records

Expansion highlights6 records

Hannover Medical School competitors and assessment

Company assessment

Others

  • Helmholtz Centre for Infection Research (HZI): German national research center for infection biology with an active collaborative partnership with MHH on One-Health and microbiome research. Not a direct competitor but a key strategic research partner and ecosystem participant.

Direct peers

  • Charité – Universitätsmedizin Berlin: Europe's largest university hospital and one of Germany's leading academic medical centers, combining clinical care, biomedical research, and medical education across all major specialties. Directly comparable to MHH in mission, structure, and German public-university-hospital operating model.
  • University Hospital Cologne (Uniklinik Köln): Major German university medical center with comparable size, public-university governance, and integrated research-clinical-education mission to MHH.
  • University Hospital of the Ludwig-Maximilians-Universität München (LMU Klinikum): Comprehensive German university medical center delivering clinical care, biomedical research, and medical education. Directly comparable to MHH in scale, public-university governance, and breadth of specialty services.
  • Heidelberg University Hospital (Universitätsklinikum Heidelberg): Major German university medical center internationally recognized for translational oncology research, complex clinical care, and biomedical innovation. Directly comparable to MHH in combining academic medicine, research infrastructure, and high-acuity specialty services.
  • University Hospital Freiburg: Comprehensive German university medical center with comparable breadth of specialty clinical care and biomedical research output to MHH.
  • University Hospital Frankfurt (Universitätsklinikum Frankfurt): German public university medical center delivering integrated clinical care, research, and teaching. Comparable to MHH in mission and structural operating model.
  • University Hospital Tübingen: German university hospital with strong research profile in imaging, neuroscience, and translational medicine. Comparable to MHH as a peer German public university medical center with similar operating model.
  • University Medical Center Hamburg-Eppendorf (UKE): Hamburg-based university hospital providing full-spectrum clinical care alongside major biomedical research programs. Comparable to MHH in mission, German public-university structure, and translational research focus.

Regional players

  • Karolinska University Hospital: Sweden's premier university hospital affiliated with Karolinska Institutet, combining clinical care and world-class biomedical research. Comparable to MHH in academic-medical-center mission but operates in a different national healthcare system.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

Hannover Medical School social profiles

Digital presence

Hannover Medical School compliance and trust

Trust signal

Compliance3 records

Hannover Medical School financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Hannover Medical School leadership team

Management profile

Number of profiles

Profiles7 records

Hannover Medical School funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Hannover Medical School M&A and investment

M&A and investment

M&A

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Hannover Medical School

What does Hannover Medical School do?

Medizinische Hochschule Hannover (MHH) is a public German university medical center that delivers inpatient and outpatient clinical care across all major specialties (including transplantation, cardiology, oncology, and rare diseases), conducts biomedical and clinical research, and provides academic medical education from undergraduate through postdoctoral levels. The institution operates hospital facilities in Hannover, supports doctoral and clinician-scientist training programs, and runs centralized research infrastructure such as the Hannover Unified Biobank (HUB) and MeDIC.

Is Hannover Medical School a public or private company?

Hannover Medical School is a private company. It is classified as state government owned and is currently operating.

When was Hannover Medical School founded?

Hannover Medical School was founded in 1965. It employs 5,001 to 10,000 people.

Where is Hannover Medical School based?

Hannover Medical School is headquartered in Hanover, Germany, in the Europe region.

Who are Hannover Medical School's main competitors?

Helmholtz Centre for Infection Research (HZI) is listed as an others. Direct peers are Charité – Universitätsmedizin Berlin, University Hospital Cologne (Uniklinik Köln), University Hospital of the Ludwig-Maximilians-Universität München (LMU Klinikum), Heidelberg University Hospital (Universitätsklinikum Heidelberg), University Hospital Freiburg, University Hospital Frankfurt (Universitätsklinikum Frankfurt), University Hospital Tübingen and University Medical Center Hamburg-Eppendorf (UKE). Karolinska University Hospital is listed as a regional player.

Does Hannover Medical School have an API?

No public API is recorded for Hannover Medical School.

What industry is Hannover Medical School in?

Hannover Medical School's product category is University Hospital and Academic Medical Center Services. Its primary akta.pro industry code is EDAHAGAI, Biomedical Sciences & Medical Research Institutes (University-Based), with a secondary code of HLAFAHAC, Oncology & Cancer Specialty Hospitals. Its NAICS code is 62211 and its SIC code is 8062.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
MedicalxpressNatural compound shows promise against C. difficile while largely sparing healthy gut bacteriaResearchers at Hannover Medical School and partners found argyrin B, a natural compound, highly effective against C. difficile in a mouse model while sparing beneficial gut bacteria. The compound barely enters the bloodstream, reducing side effects. Follow-up studies will determine optimal dosage and efficacy against recurrent infections.MedicalxpressTiny blood clots help guide blood flow as placenta develops, mouse study findsA mouse study at Hannover Medical School found tiny blood clots at the maternal-embryonic interface regulate placental blood flow during development. These microthrombi contain platelets, clotting factors, and complement protein C3, and their absence impairs placental development. The findings may inform treatments for preeclampsia and recurrent miscarriages.3D Printing IndustryResearchers develop architected TPMS membranes for biohybrid artificial lungsResearchers from Hannover Medical School, RWTH Aachen, TU Darmstadt and the University of Twente published in Advanced Materials a study using additive manufacturing to create artificial lungs with triply periodic minimal surface membranes instead of hollow fiber bundles. Simulations showed a 1 mm unit cell with 10 µm walls delivered 87.8% higher oxygen transfer and 56% fewer stagnation regions, while endothelialization of xPDMS maintained cell viability above 80%.Quiver QuantitativeSciSparc Subsidiary NeuroThera Initiates Phase IIb SCI-110 Clinical Trial Site at Hannover Medical School for Adult Tourette Syndrome | Quiver QuantitativeSciSparc Ltd.'s subsidiary NeuroThera Labs has initiated a Phase IIb clinical trial site at Hannover Medical School in Germany for SCI-110, its proprietary cannabinoid-based treatment candidate for Tourette Syndrome in adults. The randomized, double-blind, placebo-controlled trial will evaluate the efficacy, safety, and tolerability of SCI-110 in patients aged 18-65, with the primary endpoint measuring change in tic severity at weeks 12 and 26. The Phase IIb study builds on positive Phase IIa results that demonstrated an average 21% tic reduction, and the trial is also being conducted at Yale Child Study Center in Connecticut and Tel Aviv Sourasky Medical Center in Israel.GlobeNewswireSciSparc: NeuroThera Labs Announces Initiation of Phase IIb Clinical Trial at Hannover Medical School in Germany for Innovative Treatment of Tourette SyndromeSciSparc Ltd.'s subsidiary NeuroThera Labs announced the initiation of a Phase IIb clinical trial site at Hannover Medical School in Germany for SCI-110, a cannabinoid-based treatment candidate for Tourette Syndrome in adults, following regulatory clearance from Germany's Federal Institute for Drugs and Medical Devices. The randomized, double-blind, placebo-controlled trial builds on Phase IIa results showing a 21% average tic reduction and will also be conducted at Yale Child Study Center in Connecticut and Tel Aviv Sourasky Medical Center in Israel. NeuroThera Labs stated the therapy targets an unmet medical need with limited treatment options for adults with persistent, severe symptoms.Today on MedscapeWearables Generate the Data: What's Next for Chronic Care?Researchers from Hannover Medical School in Germany published a systematic review in JMIR mHealth and uHealth finding that wearable devices such as smartwatches and fitness bands can collect physiologic data including physical activity, heart rate, blood pressure, and oxygen saturation, supporting monitoring of chronic conditions like diabetes, heart failure, and cardiovascular disease. Experts note that the main challenge is no longer data collection but integrating these data into routine clinical practice through standardized, scalable, and interoperable monitoring systems combined with patient education and clinical protocols. Wearable devices can generate more than 5 gigabytes of data per patient each week, and AI techniques including deep learning are being highlighted as essential for analyzing these data and identifying biomarker signatures for early intervention.ResearchprotocolsInternational Case Studies to Identify Success Factors and Contextual Conditions in the Digital Transformation of Health Care Systems and Derive Lessons for Germany: Study Protocol for a Mixed MethodsResearchers from Hannover Medical School and Technische Universität Berlin have published a study protocol describing a mixed-methods research project examining digital transformation in nine international healthcare systems to identify success factors and develop policy recommendations for Germany. The study has completed 109 expert interviews across Estonia, Denmark, Poland, Portugal, Israel, Japan, Saudi Arabia, South Africa, and the United States, with a quantitative survey planned for late 2025 and initial results expected in 2026.WileyHuman vs. artificial intelligence: Physicians outperform ChatGPT in real‐world pharmacotherapy counsellingA study conducted at Hannover Medical School in Germany found that physician-generated responses to real-world pharmacotherapeutic queries were significantly superior to those generated by the ChatGPT AI chatbot in terms of information quality and factual correctness. Evaluators detected factually wrong information much more frequently in the AI's responses, leading researchers to strongly caution against relying on ChatGPT for clinical pharmacotherapy advice.MhhMedizinische Hochschule Hannover : 20 million euros for the medicine of the futureThe Hannover Medical School (MHH) has secured 20 million euros from the zukunft.niedersachsen funding programme to establish two new virtual centres for precision medicine research. This investment aims to expand MHH's capabilities in developing active ingredients and diagnostic approaches at the molecular and cellular levels under the leadership of Prof. Dr Michael Manns.Tu-BraunschweigWhen the car prevents strokes - TU BraunschweigResearchers from TU Braunschweig and Hannover Medical School are presenting the SmartCar at the Medica trade fair, demonstrating how vehicle interiors can serve as medical diagnostic spaces. The system uses integrated sensors to passively monitor vital signs like ECG and heart rate, aiming to detect early signs of cardiovascular diseases such as atrial fibrillation that can lead to strokes.